Cited by 259Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAluminum toxicity and tolerance in plants and animals

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Metal-associated amyloid-β species in Alzheimer's disease

Pithadia, Amit S, Lim, Mi Hee·2012·Current Opinion in Chemical Biology

Abstract

Highly concentrated metals such as Cu, Zn, and Fe are found in amyloid-β (Aβ) plaques within the brain of Alzheimer's disease (AD). In vitro and in vivo studies have suggested that metal binding to Aβ could facilitate Aβ aggregation and generate reactive oxygen species (ROS), which could contribute to the neuropathogenesis of AD. The connection between metal-Aβ interaction/reactivity and AD development, however, has not been clearly revealed owing to the complexity of the disease. In this review, metal-Aβ interaction/reactivity and its relation to neurotoxicity are briefly discussed. Additionally, our review illustrates the recent progress of small molecules, capable of targeting metal-Aβ species and modulating their interaction/reactivity, which could offer a promising approach to interrogate their role in AD.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.cbpa.2012.01.016

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 14 references

Research works printed but not linked: 31

  1. Alzheimer's Association, 2011, Alzheimer's disease facts and figures, Alzheimers Dement, 7, 208, 10.1016/j.jalz.2011.02.004 · DOI
  2. Hardy, 1992, Alzheimer's disease: the amyloid cascade hypothesis, Science, 256, 184, 10.1126/science.1566067 · DOI · Paper page
  3. Wang, 2006, Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives, Drug Discov Today, 11, 931, 10.1016/j.drudis.2006.08.004 · DOI
  4. Kurz, 2011, Amyloid clearance as a treatment target against Alzheimer's disease, J Alzheimers Dis, 24, 61, 10.3233/JAD-2011-102139 · DOI
  5. Maynard, 2005, Metals and amyloid-β in Alzheimer's disease, Int J Exp Pathol, 86, 147, 10.1111/j.0959-9673.2005.00434.x · DOI
  6. Bonda, 2011, Role of metal dyshomeostasis in Alzheimer's disease, Metallomics, 3, 267, 10.1039/c0mt00074d · DOI
  7. Jomova, 2011, Advances in metal-induced oxidative stress and human diseases, Toxicology, 283, 65, 10.1016/j.tox.2011.03.001 · DOI
  8. DeToma, 2012, Misfolded proteins in Alzheimer's disease and type II diabetes, Chem Soc Rev, 41, 608, 10.1039/C1CS15112F · DOI
  9. Burdette, 2003, Meeting of the minds: metalloneurochemistry, Proc Natl Acad Sci USA, 100, 3605, 10.1073/pnas.0637711100 · DOI
  10. Que, 2008, Metals in neurobiology: probing their chemistry and biology with molecular imaging, Chem Rev, 108, 1517, 10.1021/cr078203u · DOI
  11. Bush, 2008, Therapeutics for Alzheimer's disease based on the metal hypothesis, Neurotherapeutics, 5, 421, 10.1016/j.nurt.2008.05.001 · DOI
  12. Frederickson, 2005, The neurobiology of zinc in health and disease, Nat Rev Neurosci, 6, 449, 10.1038/nrn1671 · DOI
  13. Faller, 2009, Copper and zinc binding to amyloid-β: coordination, dynamics, aggregation, reactivity and metal-ion transfer, ChemBioChem, 10, 2837, 10.1002/cbic.200900321 · DOI · Paper page
  14. Gaggelli, 2006, Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyothrophic lateral sclerosis), Chem Rev, 106, 1995, 10.1021/cr040410w · DOI · Paper page
  15. Drew, 2011, The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide, Acc Chem Res, 44, 1146, 10.1021/ar200014u · DOI
  16. Karr, 2008, Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-β peptide, Biochemistry, 47, 5006, 10.1021/bi702423h · DOI
  17. Dorlet, 2009, Pulse EPR spectroscopy reveals the coordination sphere of copper(II) ions in the 1–16 amyloid-β peptide: a key role of the first two N-terminus residues, Angew Chem Int Ed, 48, 9273, 10.1002/anie.200904567 · DOI
  18. Shearer, 2008, The amyloid-β peptide of Alzheimer's disease binds CuI in a linear bis-His coordination environment: insight into a possible neuroprotective mechanism for the amyloid-β peptide, J Am Chem Soc, 130, 17826, 10.1021/ja805940m · DOI
  19. Himes, 2008, Structural studies of copper(I) complexes of amyloid-β peptide fragments: formation of two-coordinate bis(histidine) complexes, Angew Chem Int Ed, 47, 9084, 10.1002/anie.200803908 · DOI
  20. Shearer, 2010, Cu K-edge X-ray absorption spectroscopy reveals differential copper coordination within amyloid-β oligomers compared to amyloid-β monomers, Chem Commun, 46, 9137, 10.1039/c0cc02446e · DOI
  21. Feaga, 2011, Affinity of Cu+ for the copper-binding domain of amyloid-β peptide of Alzheimer's disease, Inorg Chem, 50, 1614, 10.1021/ic100967s · DOI
  22. Bousejra-ElGarah, 2011, Iron(II) binding to amyloid-β, the Alzheimer's peptide, Inorg Chem, 50, 9024, 10.1021/ic201233b · DOI
  23. Noy, 2008, Zinc-amyloid β interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species, J Am Chem Soc, 130, 1376, 10.1021/ja076282l · DOI
  24. Chen, 2011, Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-β stability, oligomerization, and aggregation, J Biol Chem, 286, 9646, 10.1074/jbc.M110.177246 · DOI
  25. Pramanik, 2011, Active site environment of heme-bound amyloid β peptide associated with Alzheimer's disease, J Am Chem Soc, 133, 81, 10.1021/ja1084578 · DOI
  26. Atamna, 2006, Amyloid-β peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease, Proc Natl Acad Sci USA, 103, 3381, 10.1073/pnas.0600134103 · DOI
  27. Atamna, 2006, Heme binding to amyloid β peptide: mechanistic role in Alzheimer's disease, J Alzheimers Dis, 10, 255, 10.3233/JAD-2006-102-310 · DOI
  28. Adlard, 2008, Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ, Neuron, 59, 43, 10.1016/j.neuron.2008.06.018 · DOI · Paper page
  29. Kung, 2001, Novel stilbenes as probes for amyloid plaques, J Am Chem Soc, 123, 12740, 10.1021/ja0167147 · DOI
  30. Ono, 2004, Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro, J Neurosci Res, 75, 742, 10.1002/jnr.20025 · DOI · Paper page
  31. Wu, 2008, Sequestration of copper from β-amyloid promotes selective lysis by cyclen-hybrid cleave agents, J Biol Chem, 283, 31657, 10.1074/jbc.M804722200 · DOI

Cited by

Sorted by citations

Items 101–200 of 237

Metadata

Authors
Pithadia, A. S., & Lim, M. H.
Affiliations
University of Michigan (US)
Corresponding author
Lim, Mi Hee
Venue
Current Opinion in Chemical Biology
Publisher
Elsevier BV
Published
2012-04
Volume
16
Issue
1-2
Pages
67-73
ISSN
1367-5931 (ISSN-L)
OpenAlex
W1984223653
Cited by
259
References
48
Citations by year
2026: 3 · 2025: 12 · 2024: 10 · 2023: 14 · 2022: 11 · 2021: 17 · 2020: 21 · 2019: 28 · 2018: 30 · 2017: 25 · 2016: 16 · 2015: 18 · 2014: 26 · 2013: 20 · 2012: 8
FWCI
2.48
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Chemical Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Aluminum toxicity and tolerance in plants and animals
Keywords
Alzheimer's disease, amyloid-beta, metal ion binding, copper, zinc, iron, amyloid plaques, amyloid-beta aggregation, reactive oxygen species, neurotoxicity, metal chelators
MeSH terms
Alzheimer Disease, Amyloid, Humans, Metals, Reactive Oxygen Species

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review